LFB (Laboratoire Français du Fractionnement et des Biotechnologies) is a biopharmaceutical company that develops, manufactures, and markets therapeutic proteins for patients with serious and rare diseases. It provides plasma-derived or recombinant medicinal products with a focus on immunology, hemostasis, and intensive care.